• 1. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 2. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Heterocyclic fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Heterocyclic fatty acids

Comprehensive Overview of 2-methyl-5-(morpholin-4-yl)pentanoic acid (CAS No. 1564762-59-9)

2-methyl-5-(morpholin-4-yl)pentanoic acid (CAS No. 1564762-59-9) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research due to its unique structural features and potential applications. This compound, characterized by its morpholine and carboxylic acid functional groups, is often explored for its role in drug discovery, particularly in the development of small-molecule inhibitors and bioactive intermediates. Researchers are increasingly interested in its synthetic pathways, physicochemical properties, and biological activity, making it a subject of ongoing studies in medicinal chemistry.

The molecular structure of 2-methyl-5-(morpholin-4-yl)pentanoic acid includes a morpholine ring, which is known for enhancing solubility and bioavailability in drug candidates. This feature aligns with current trends in pharmaceutical development, where improving drug delivery systems and oral bioavailability are critical priorities. The compound's CAS No. 1564762-59-9 serves as a unique identifier in databases like PubChem and Reaxys, facilitating its study in high-throughput screening and structure-activity relationship (SAR) analyses. Its potential as a building block for more complex molecules further underscores its relevance in synthetic chemistry.

In recent years, the demand for custom synthesis and research chemicals like 2-methyl-5-(morpholin-4-yl)pentanoic acid has surged, driven by advancements in precision medicine and targeted therapy. This compound is frequently discussed in forums and publications focusing on kinase inhibitors and GPCR modulators, reflecting its versatility in drug design. Additionally, its stability under physiological conditions and compatibility with common coupling reagents make it a valuable tool for peptide and peptidomimetic synthesis.

From an industrial perspective, 2-methyl-5-(morpholin-4-yl)pentanoic acid is often procured by contract research organizations (CROs) and pharmaceutical companies for exploratory projects. Its scalable synthesis and cost-effective production are key factors driving its adoption. Furthermore, the compound's regulatory compliance and safety profile are frequently evaluated to ensure its suitability for large-scale applications. These aspects are particularly relevant given the growing emphasis on green chemistry and sustainable manufacturing practices.

In summary, 2-methyl-5-(morpholin-4-yl)pentanoic acid (CAS No. 1564762-59-9) represents a promising candidate for diverse applications in drug discovery and chemical synthesis. Its structural attributes, combined with its pharmacological potential, position it as a compound of interest for researchers and industry professionals alike. As the field of medicinal chemistry continues to evolve, this molecule is likely to play an increasingly important role in the development of next-generation therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)